True Wealth Design »

Allogene Therapeutics shares owned by True Wealth Design

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by True Wealth Design from 13F filings

Historical chart of True Wealth Design investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by True Wealth Design consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by True Wealth Design

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0k 809 2.44
2025-12-31 $450 328 1.37
2025-09-30 $267 216 1.24

More positions owned by True Wealth Design

Ea Series Trust Alpha Arch 1-3 (BOXX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Intl High Profit (DIHP)
Simplify Exchange Traded Fun Intmd Term Trsry (TYA)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Simplify Exchange Traded Fun Bond Bull Etf (RFIX)
American Centy Etf Tr Intl Eqt Etf (AVDE)
American Centy Etf Tr Us Eqt Etf (AVUS)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Equity Market (DFUS)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for True Wealth Design

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Patient Square Capital
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Two Sigma Investments
Wildcat Capital Management
Two Sigma Advisers
State Street Corporation
Candriam Luxembourg S.C.A.

View all funds holding Allogene Therapeutics